Retinoic acid receptor-beta as a prognostic indicator in stage 1 non-small cell lung cancer

Journal of Clinical Oncology

Volumn 18, Issue 15, 2000, Pages 2798-2804

  Khuri, Fadlo R ^a   Lotan, Reuben ^a   Kemp, Bonnie L ^a   Lippman, Scott M ^a   Wu, Hong ^a   Feng, Lei ^a   Lee, Jack J ^a   Cooksley, Catherine S ^a   Parr, Bianca ^a   Chang, Evelyn ^a   Walsh, Garrett L ^a   Lee, Jin S ^a   Hong, Waun K ^a   Xu, Xiao Chun ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIGENIN; MESSENGER RNA; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0033899212     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.15.2798     Document Type: Article

References (39)

1. Cancer statistics
2. Cancer of the lung
3. Lobectomy for stage I lung cancer
4. Survival of patients surgically treated for stage I lung cancer
5. Results of surgery in non-small cell lung cancer
6. Prognosis and survival in resected lung carcinoma based on the new international staging system
7. K-ras oncogene activation as a poor prognostic marker in adenocarcinoma of the lung
8. Expression of blood-group antigen A: A favorable prognostic factor in non-small cell lung cancer
9. bcl-2 protein in non-small-cell lung carcinoma
10. Immunocytochemical markers in stage I lung cancer: Relevance to prognosis
11. Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: Clinical implications
12. The retinoid receptors
13. A decade of molecular biology of retinoic acid receptors
14. Differential induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl) retinamide in human head and neck squamous cell carcinoma cell lines
15. Higher potency of N-(4-hydroxyphenyl) retinamide than all-trans-retinoic acid in induction of apoptosis in non-small cell lung cancer cell lines
16. Differentially expressed isoforms of the mouse retinoic acid receptor beta are generated by usage of two promoters and alternative splicing
17. RAR-beta-4, A retinoic acid receptor isoform is generated from RAR-beta-2 by alternative splicing and usage of a CUG initiator codon
18. Regulation of RAR beta expression by RAP,- and RXR-selective retinoids in human lung cancer cell lines: Effect on growth inhibition and apoptosis induction
19. Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells
20. Lung tumors in mice expressing an antisense RAR-beta-2 transgene
21. Hyperplasia and tumours in lung, breast, and other tissues in mice carrying a RAR-beta-4-like transgene
22. Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues
23. Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: Implications for lung cancer development
24. Nuclear retinoid receptor beta in bronchial epithelium of smokers before and during chemoprevention
25. High frequency of retinoic acid receptor beta abnormalities in human lung cancer
26. A retinoic acid receptor-specific element controls the retinoic acid receptor-beta promoter
27. Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin
28. Placebo-controlled trial of 13-cis-retinoic acid activity on retinoic acid receptor-beta expression in a population at high risk: Implications for chemoprevention of lung cancer
29. Expression of retinoid receptor genes and proteins in non-small-cell lung cancer
30. Favorable prognostic significance of high-level retinoic acid receptor beta expression in neuroblastoma mediated by effects on cell cycle regulation
31. Retinoic acid receptor beta mediates the growth inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells
32. The targeted disruption of both alleles of RAR-beta-2 in F9 embryonal carcinoma cells resulted in the loss of retinoic acid-associated growth arrest
33. Retinoid refractoriness occurs during lung carcinogenesis despite functional retinoid receptors
34. A specific defect in the retinoic acid response associated with human lung cancer cell lines
35. Human lung cancer cell lines exhibit resistance to retinoic acid treatment
36. Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer
37. Inhibition of cyclooxygenase-2 expression: An approach to preventing head and neck cancer
38. COX-2 overexpression correlates with RAR-beta expression in stage I non-small cell lung cancer (NSCLC) and is a marker of poor prognosis
39. Phase III Intergroup trial of 13-cis-retinoic acid to prevent second primary tumors in stage I non-small cell lung cancer (NSCLC): Interim Report of NCI I19-000117